In contrast to the transient character of virus-triggered or passively transmitted anti-PF4 disorders, there is an only recently recognized patient group in whom VITT-like antibodies have persisted over years and have triggered chronic recurrent thrombosis with thrombocytopenia (Table 2) [59,63,[92], [93], [94]]. Here, PF4 is linked to Thrombocytopenia.